<DOC>
	<DOCNO>NCT00578851</DOCNO>
	<brief_summary>The objective study gather clinical survivorship information C2a-Taper™ Acetabular System , ceramic-on-ceramic hip articulate system .</brief_summary>
	<brief_title>A Clinical Investigation C2a-Taper™ Acetabular System</brief_title>
	<detailed_description>Study Design : Phase 1 Sites collect follow type data : Clinical-Total Harris Hip Score , Radiographic Evaluation- measurement acetabular femoral component Survivorship-removal/revision one component ( i.e . liner , head , shell and/or stem ) Safety- All adverse event Follow-up Visit schedule - 6 week ± 2 week - 6 month ± 1 month - 1 year ± 3 month - 2 year ± 3 month - 3 year ± 3 month - 4 year ± 3 month - 5 year ± 3 month Phase 2 : Patients continue follow annual basis ( Years 6-10 ) via mail . A self assessment form send directly subject annual basis start 6th post-operative year .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation , Congenital</mesh_term>
	<criteria>Skeletally mature patient noninflammatory degenerative joint disease osteoarthritis , avascular necrosis , congenital hip dysplasia , traumatic arthritis Patients : Osteoporosis , metabolic disorder , osteomalacia , rapid joint destruction , vascular insufficiency , muscular atrophy , neuromuscular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hip Arthroplasty</keyword>
	<keyword>Hip Arthritis</keyword>
</DOC>